FMC Corporation expands novel fluindapyr fungicide technology to EMEA region

FMC Corporation (NYSE: FMC), a leading global agricultural sciences company,  announced regulatory approval for Tremisia^® fungicide in Ukraine, marking the first introduction of the company's novel fluindapyr technology in the European, Middle East, and Africa (EMEA) region. The approval covers oilseed rape, sunflower, and wheat across more than 10 million hectares of Ukrainian farmland.

"The registration advances the commercialization of FMC’s novel fluindapyr fungicide technology,″ said Sebastià Pons, vice president, president of FMC EMEA. "Ukraine ranks among the world's largest exporters of sunflower, oilseed rape, and wheat, making it a strategically important agricultural market. The Tremisia^® fungicide approval brings Ukrainian growers our most advanced fungicide technology and demonstrates FMC's continued commitment to science and innovation.″

Tremisia^® fungicide combines FMC's proprietary fluindapyr molecule with flutriafol, delivering a dual mode of action to help maintain a healthy crop for an extended period. This fungicide targets a broad spectrum of economically significant diseases, including Alternaria and Sclerotinia in sunflower, and Septoria and rust in wheat.

"This registration fills an important gap in disease management options for Ukrainian growers, providing a high-performance tool to protect their crops from devastating disease," said Nataliia Savchenko, FMC Ukraine country leader. "Disease pressures pose ongoing challenges to crop productivity in Ukraine's intensive cropping systems. Tremisia^® fungicide will offer growers the freedom to choose a best-in-class solution that integrates seamlessly into their existing disease management programs.″

The Ukraine registration builds on FMC's successful commercialization of fluindapyr-based products in Argentina, Brazil, Mexico, Paraguay, South Korea, and the United States, with conditional approval secured in the Philippines earlier this year. Pending regulatory decisions, FMC anticipates launching fluindapyr-based products in Bolivia, Chile, Colombia, Honduras, and India, further expanding global access to this innovative fungicide technology.